Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.108 (
TAT
)
2,389
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The ECLIA is a versatile method which is able to quantify endogenous and recombinant protein amounts in a 96-well format. To demonstrate ECLIA efficiency, this assay was used to analyze intrinsic levels of
MeCP2
in mouse brain tissue and the uptake of
TAT
-
MeCP2
in human dermal fibroblasts. The
MeCP2
-ECLIA produces highly accurate and reproducible measurements with low intra- and inter-assay error. In summary, we developed a quantitative method for the evaluation of
MeCP2
protein variants that can be utilized in high-throughput screens.
...
PMID:An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants. 3251 Apr 86
